Sodium chromate Cr-51

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Sodium chromate Cr-51
DrugBank Accession Number
DB09380
Background

Not Available

Type
Small Molecule
Groups
Approved
Structure
Weight
Average: 160.92
Monoisotopic: 160.90396881
Chemical Formula
CrNa2O4
Synonyms
  • Chromate (51 Cr) de sodium
  • Cromato sodico (51 Cr)
  • Natrii chromas (51 Cr)
  • Sodium chromate (51 Cr)
  • Sodium chromate (51Cr)
  • Sodium chromate Cr 51

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Active Moieties
NameKindUNIICASInChI Key
Chromate ion Cr-51unknownSVU4HTP02MNot AvailableZCDOYSPFYFSLEW-HONVGLGOSA-N
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Chromitope SodiumInjection, solution.2 mCi/1mLIntravenousBracco Diagnostics, Inc1971-12-272012-09-01US flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of inorganic compounds known as miscellaneous chromates. These are inorganic compounds in which the largest metallic oxoanion is chromate, to which either no atom or a non metal atom is bonded.
Kingdom
Inorganic compounds
Super Class
Mixed metal/non-metal compounds
Class
Miscellaneous mixed metal/non-metals
Sub Class
Miscellaneous metallic oxoanionic compounds
Direct Parent
Miscellaneous chromates
Alternative Parents
Alkali metal chromates / Inorganic sodium salts / Inorganic oxides
Substituents
Alkali metal chromate / Chromate / Inorganic oxide / Inorganic salt / Inorganic sodium salt
Molecular Framework
Not Available
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
XI776WYU0N
CAS number
10039-53-9
InChI Key
PXLIDIMHPNPGMH-PJWPDVOUSA-N
InChI
InChI=1S/Cr.2Na.4O/q;2*+1;;;2*-1/i1-1;;;;;;
IUPAC Name
disodium dioxo(51Cr)chromiumbis(olate)
SMILES
[Na+].[Na+].[O-][51Cr]([O-])(=O)=O

References

General References
Not Available
ChemSpider
2338409
RxNav
91510

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntravenous.2 mCi/1mL
Injection, solutionParenteral37 MBq/ml
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility262.0 mg/mLALOGPS
logP-0.7ALOGPS
logP-2.5Chemaxon
logS0.21ALOGPS
pKa (Strongest Acidic)-2.3Chemaxon
Physiological Charge-2Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area80.26 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity5.77 m3·mol-1Chemaxon
Polarizability6.04 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at November 30, 2015 19:10 / Updated at October 06, 2020 17:43